Published in J Infect Dis on December 01, 1998
Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis (2008) 3.19
Sexual Orientation Identity Disparities in Awareness and Initiation of the Human Papillomavirus Vaccine Among U.S. Women and Girls: A National Survey. Ann Intern Med (2015) 2.03
Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. Am J Public Health (2001) 1.93
Use of preventive health behaviors by lesbian, bisexual, and heterosexual women: questionnaire survey. West J Med (2000) 1.57
Prevalence of human papillomavirus in adolescent girls before reported sexual debut. J Infect Dis (2014) 1.47
Sexual practices, risk perception and knowledge of sexually transmitted disease risk among lesbian and bisexual women. Perspect Sex Reprod Health (2005) 1.25
Sexual risk behaviors and psychosocial health concerns of female-to-male transgender men screening for STDs at an urban community health center. AIDS Care (2013) 1.08
Barriers to cervical cancer screening among lesbians. J Womens Health (Larchmt) (2010) 1.08
Emerging Sexual Health Issues Among Women Who Have Sex with Women. Curr Infect Dis Rep (2012) 1.02
Forced sexual experiences as risk factor for self-reported HIV infection among southern African lesbian and bisexual women. PLoS One (2013) 1.02
Chlamydia trachomatis infection among women reporting sexual activity with women screened in Family Planning Clinics in the Pacific Northwest, 1997 to 2005. Am J Public Health (2010) 0.99
Reproductive health screening disparities and sexual orientation in a cohort study of U.S. adolescent and young adult females. J Adolesc Health (2011) 0.98
Barriers to infectious disease care among lesbians. Emerg Infect Dis (2004) 0.95
Sexually transmitted disease (STD) diagnoses and mental health disparities among women who have sex with women screened at an urban community health center, Boston, MA, 2007. Sex Transm Dis (2010) 0.93
HPV vaccination among lesbian and bisexual women: Findings from a national survey of young adults. Vaccine (2014) 0.93
Understanding cervical cancer screening among lesbians: a national survey. BMC Public Health (2013) 0.91
Sexual orientation disparities in Papanicolaou test use among US women: the role of sexual and reproductive health services. Am J Public Health (2013) 0.90
Sexual discordance and sexual partnering among heterosexual women. Arch Sex Behav (2014) 0.86
HIV risk, substance use, and suicidal behaviors among Asian American lesbian and bisexual women. AIDS Educ Prev (2012) 0.84
Oral HPV infection and sexuality: a cross-sectional study in women. Int J Mol Sci (2011) 0.84
Acceptability of home-based chlamydia and gonorrhea testing among a national sample of sexual minority young adults. Perspect Sex Reprod Health (2015) 0.83
Bacterial STDs and perceived risk among sexual minority young adults. Perspect Sex Reprod Health (2011) 0.82
Health care problems of lesbian, gay, bisexual, and transgender patients. West J Med (2000) 0.81
The impact of smoking on HPV infection and the development of anogenital warts. Int J Colorectal Dis (2014) 0.79
Cervical cancer screening (Pap testing) behaviours and acceptability of human papillomavirus self-testing among lesbian and bisexual women aged 21-26 years in the USA. J Fam Plann Reprod Health Care (2014) 0.78
Women Who Have Sex with Women in Kenya and Their Sexual and Reproductive Health. LGBT Health (2015) 0.77
The Incidence of Human Papillomavirus in Tanzanian Adolescent Girls Before Reported Sexual Debut. J Adolesc Health (2015) 0.77
Sex of Sexual Partners and Human Papillomavirus Vaccination Among U.S. Girls and Women. Am J Prev Med (2015) 0.76
Genital and oral human papillomavirus infection in a patient from the group of women who have sex with women. Clinics (Sao Paulo) (2010) 0.75
SCREENING FOR SEXUALLY TRANSMITTED INFECTIONS (STIs) AMONG A HETEROGENEOUS GROUP OF WSW(M). Int J Sex Health (2015) 0.75
Risk behaviors for reproductive tract infection in women who have sex with women in Beijing, China. PLoS One (2012) 0.75
Etiology of nongonococcal urethritis. N Engl J Med (1975) 9.61
Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature (1998) 7.81
Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08
A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med (1992) 5.96
Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significance. N Engl J Med (1974) 5.68
Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA (1986) 4.93
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA (1999) 4.91
PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time. Am J Clin Pathol (1991) 4.65
Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat Med (1996) 4.51
Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst (1998) 4.42
Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol (1996) 4.25
The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J Virol (1991) 4.18
The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA (1988) 3.73
Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med (1988) 3.71
Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob Agents Chemother (1985) 3.66
Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol (1993) 3.65
Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med (1992) 3.56
Low antibiotic resistance of gonococci causing disseminated infection. N Engl J Med (1973) 3.48
Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis (2000) 3.36
Epidemiology of genital human papillomavirus infection. Epidemiol Rev (1988) 3.32
Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis (1996) 3.23
DNA hybridization technique for the detection of Neisseria gonorrhoeae in men with urethritis. J Infect Dis (1983) 3.11
Clinical manifestations of vaginal trichomoniasis. JAMA (1989) 2.97
Gas chromatography as a potential means of diagnosing arthritis. I. Differentiation between staphylococcal, streptococcal, gonococcal, and traumatic arthritis. J Infect Dis (1974) 2.87
Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology (1996) 2.83
Sexual mixing patterns of patients attending sexually transmitted diseases clinics. Sex Transm Dis (1996) 2.76
Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol (1990) 2.68
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev (1997) 2.65
Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol (1998) 2.64
Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men. J Infect Dis (2000) 2.63
The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J Virol (1992) 2.61
Genital herpes and public health: addressing a global problem. JAMA (2000) 2.60
A case-control study of necrotizing fasciitis during primary varicella. Pediatrics (1999) 2.54
Sexual mixing patterns in the spread of gonococcal and chlamydial infections. Am J Public Health (1999) 2.54
HIV counseling and testing: does it work? Am J Public Health (1988) 2.47
Chlamydia trachomatis urethral infections in men. Prevalence, risk factors, and clinical manifestations. Ann Intern Med (1984) 2.44
Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy. Sex Transm Dis (1997) 2.42
Epidemiology of penicillinase-producing Neisseria gonorrhoeae infections: analysis by auxotyping and serogrouping. N Engl J Med (1982) 2.36
Antigens of Treponema pallidum recognized by IgG and IgM antibodies during syphilis in humans. J Infect Dis (1985) 2.29
Circumcision and sexually transmitted diseases. Am J Public Health (1994) 2.27
The oncogenic potential of herpes simplex viruses: evidence for a 'hit-and-run' mechanism. Nature (1983) 2.26
Detection of herpes simplex RNA in human sensory ganglia. Virology (1979) 2.23
Use of sequential enzyme immunoassay and direct fluorescent antibody tests for detection of Chlamydia trachomatis infections in women. J Clin Microbiol (1990) 2.22
The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis (1996) 2.21
Fluorescent monoclonal antibody for confirmation of Neisseria gonorrhoeae cultures. J Clin Microbiol (1987) 2.21
Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol (2001) 2.18
The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol (1993) 2.12
Limited transcription of the herpes simplex virus genome when latent in human sensory ganglia. J Virol (1982) 2.12
Association between vaginal douching and acute pelvic inflammatory disease. JAMA (1990) 2.11
Molecular epidemiology of Haemophilus ducreyi infections. Ann Intern Med (1981) 2.07
Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst (1997) 2.06
Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc Natl Acad Sci U S A (1994) 2.02
Monoclonal antibodies for diagnosis of infectious diseases in humans. Science (1983) 2.02
Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol (1994) 2.00
The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J Virol (1994) 1.97
Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis (2001) 1.97
Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. Am J Public Health (2001) 1.93
Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res (1996) 1.93
HIV prevalence, previous HIV testing, and condom use with clients and regular partners among Senegalese commercial sex workers. Sex Transm Infect (2007) 1.91
Elimination and reintroduction of primary and secondary syphilis. Am J Public Health (1999) 1.91
Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res (2001) 1.89
Treatment of uncomplicated gonorrhea with rosoxacin. Antimicrob Agents Chemother (1981) 1.88
Transformation of NIH 3T3 cells with cloned fragments of human cytomegalovirus strain AD169. J Virol (1982) 1.88
Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis (2000) 1.87
Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Obstet Gynecol (1998) 1.84
IS861, a group B streptococcal insertion sequence related to IS150 and IS3 of Escherichia coli. J Bacteriol (1989) 1.80
Evidence of prevalent genital-type human papillomavirus infections in adults and children. J Infect Dis (1990) 1.74
Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst (1997) 1.72
Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol (1990) 1.72
Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol (1996) 1.72
Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells. Oncogene (1996) 1.71
Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids. J Virol (1994) 1.70
Nucleotide sequence of the herpes simplex virus type 2 thymidine kinase gene. J Virol (1983) 1.70
Sociodemographic distribution of gonorrhea incidence: implications for prevention and behavioral research. Am J Public Health (1991) 1.69
Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes. J Virol (2001) 1.66
Cytologic manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes. JAMA (1985) 1.66
Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components. Infect Immun (1994) 1.63
Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med (1997) 1.60
Characterization of the gene encoding herpes simplex virus type 2 glycoprotein C and comparison with the type 1 counterpart. J Virol (1985) 1.60
Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. Cancer Res (1995) 1.59
Differences in the therapeutic response of chlamydia-positive and chlamydia-negative forms of nongonococcal urethritis. J Am Vener Dis Assoc (1976) 1.58
E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. J Virol (2001) 1.58
Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation. J Virol (1996) 1.57
Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest. Mol Cell Biol (1999) 1.56
Neonatal gonococcal infection. I. Orogastric contamination with Neisseria gonorrhoea. JAMA (1973) 1.56
Sequence and structural requirements of a herpes simplex viral DNA replication origin. Mol Cell Biol (1988) 1.55
Transformation of rodent cells by a cloned DNA fragment of herpes simplex virus type 2. J Virol (1981) 1.54